Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise thereby ensuring our continued growth.

Our balanced research and development portfolio is divided into three categories: life cycle management, market development and new product development.

Lifecycle management ensures continuous product improvement by maintaining and increasing competitiveness within our existing product range.
Market development brings therapies to new markets and new indications by maximizing market opportunities for our existing product range.
New product development creates specialty therapies to treat life-threatening diseases. It ensures long-term growth primarily through projects aligned with our current marketing channels.

For a brief description of any of the products listed in our pipeline please visit the Product Pipeline Description page.

Research /
Pre-Clinical

Clinical
Development

Registration/
Post-Launch

Life Cycle
Management

Immunoglobulins

Haemophilia

Specialty Products

Influenza Vaccine

Market
Development

Fibrinogen
New Indications

PCC
New Indications